* Dolby Laboratories Inc DLB.N DLB is expected to show a
fall
in quarterly revenue when it reports results on August 7 for
the period ending June 30 2024
* The San Francisco California-based company is expected to
report a 4.1% decrease in revenue to $286.183 million from
$298.37 million a year ago, according to the mean estimate from
3 analysts, based on LSEG data.The company's guidance on May 2
2024, for the period ended June 30, was for revenue between
$270.00 million and $300.00 million. (Sale is on Total Revenue
basis.)
* LSEG's mean analyst estimate for Dolby Laboratories Inc
is for
earnings of 59 cents per share. The company's EPS guidance on
May 2 2024, for the period ended June 30, was between $0.51 and
$0.66
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Dolby
Laboratories Inc is $99.00, above its last closing price
of $73.58.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Mar. 31 2024 1.19 1.19 1.27 Beat 6.4
Dec. 31 2024 0.86 0.86 1.01 Beat 17.4
Sep. 30 2023 0.53 0.53 0.65 Beat 23.4
Jun. 30 2023 0.55 0.55 0.55 Met 0
Mar. 0.95 0.98 1.26 Beat 29.2
31 2023
Dec. 31 2022 0.78 0.79 1.11 Beat 41.4
Sep. 30 2022 0.51 0.60 0.54 Missed -10
Jun. 30 2022 0.59 0.59 0.68 Beat 16.2
This summary was machine generated August 6 at 02:03 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)